LONDON (Thomson Financial) - Biopharmaceutical company Taihua PLC posted a
30 pct rise in pretax profit, during the six months to June 30, to 18.13 mln
yuan versus 13.94 mln last year, as sales jumped 44 pct to 33.6 mln yuan on
continued strong demand growth for all products.
The company also anticipates further growth in its existing markets during
the second half of the year.
tf.TFN-Europe_newsdesk@thomson.com
kkb/bsd/slj
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|